Double Medical Technology Inc.
Symbool: 002901.SZ
SHZ
31.91
CNYMarktprijs vandaag
214.6551
Koers/Winst Verhouding
0.2706
Koers/Winst Groei Verhouding
13.21B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Double Medical Technology Inc. (002901-SZ) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1661 | 1351.3 | 1179.9 | |||||||||||
balance-sheet.row.short-term-investments | 0 | 433.2 | 358.7 | 769.7 | |||||||||||
balance-sheet.row.net-receivables | 0 | 274.3 | 374.5 | 498.1 | |||||||||||
balance-sheet.row.inventory | 0 | 1193.3 | 987.4 | 670.2 | |||||||||||
balance-sheet.row.other-current-assets | 0 | 26.7 | 13 | 46.9 | |||||||||||
balance-sheet.row.total-current-assets | 0 | 3155.3 | 2726.2 | 2395.1 | |||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1070.9 | 877.7 | 698.7 | |||||||||||
balance-sheet.row.goodwill | 0 | 68.3 | 69.1 | 69.7 | |||||||||||
balance-sheet.row.intangible-assets | 0 | 136.9 | 143.2 | 148.6 | |||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 205.2 | 212.3 | 218.3 | |||||||||||
balance-sheet.row.long-term-investments | 0 | 138.9 | 0 | -768.4 | |||||||||||
balance-sheet.row.tax-assets | 0 | 8.9 | 7.2 | 8.3 | |||||||||||
balance-sheet.row.other-non-current-assets | 0 | 60.6 | 114.3 | 827.9 | |||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1484.4 | 1211.4 | 984.8 | |||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-assets | 0 | 4639.7 | 3937.6 | 3379.9 | |||||||||||
balance-sheet.row.account-payables | 0 | 281.6 | 345.4 | 296.3 | |||||||||||
balance-sheet.row.short-term-debt | 0 | 328 | 7.7 | 5 | |||||||||||
balance-sheet.row.tax-payables | 0 | 4.9 | 31.9 | 99.1 | |||||||||||
balance-sheet.row.long-term-debt-total | 0 | 261.3 | 60.9 | 13.6 | |||||||||||
Deferred Revenue Non Current | 0 | 50.1 | 48.7 | 48.5 | |||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||
balance-sheet.row.other-current-liab | 0 | 372.1 | 226.6 | 7.4 | |||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 275.3 | 114.3 | 69.7 | |||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 10.9 | 12.9 | 13.6 | |||||||||||
balance-sheet.row.total-liab | 0 | 1429 | 830.9 | 791.5 | |||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.common-stock | 0 | 414 | 414 | 405.1 | |||||||||||
balance-sheet.row.retained-earnings | 0 | 1275.9 | 1217.3 | 1333.5 | |||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 400.6 | 400.8 | 224.1 | |||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 968 | 968 | 549.7 | |||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 3058.5 | 3000.1 | 2512.5 | |||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 4639.7 | 3937.6 | 3379.9 | |||||||||||
balance-sheet.row.minority-interest | 0 | 102.2 | 106.7 | 75.9 | |||||||||||
balance-sheet.row.total-equity | 0 | 3160.7 | 3106.8 | 2588.4 | |||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||
Total Investments | 0 | 433.2 | 358.7 | 1.3 | |||||||||||
balance-sheet.row.total-debt | 0 | 600.2 | 68.6 | 18.6 | |||||||||||
balance-sheet.row.net-debt | 0 | -627.6 | -924.1 | -391.5 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 59 | 109.2 | 691.5 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 194.4 | 95.5 | 70.9 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | -3.8 | -1.7 | -3.9 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | -606 | 109.6 | 32.8 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | -217.2 | -195 | -134.4 | |||||||||||
cash-flows.row.account-receivables | 0 | 86.8 | 121.9 | -179.4 | |||||||||||
cash-flows.row.inventory | 0 | -422.2 | -418.3 | -140.4 | |||||||||||
cash-flows.row.account-payables | 0 | 118.1 | 103.1 | 189.3 | |||||||||||
cash-flows.row.other-working-capital | 0 | 0 | -1.7 | -3.9 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 659.5 | 10.8 | 16.3 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -305.7 | -285.1 | -235.1 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 1.6 | -0.3 | -88 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | -2240.4 | -4523.7 | -6977.8 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 2024.6 | 4992.5 | 6723.4 | |||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -409 | 180.8 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -519.9 | -225.6 | -396.8 | |||||||||||
cash-flows.row.debt-repayment | 0 | -530.5 | -0.7 | -8.3 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 487.5 | 76.3 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -75.7 | -2.9 | |||||||||||
cash-flows.row.dividends-paid | 0 | -9.4 | -209.4 | -324.1 | |||||||||||
cash-flows.row.other-financing-activites | 0 | -24 | 43.4 | -0.3 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 496.2 | 245.2 | -259.3 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1.1 | 4.3 | -3.6 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 235.2 | 152.3 | 13.6 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1227.8 | 214.1 | 61.8 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 992.7 | 61.8 | 48.1 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 85.8 | 128.4 | 673.3 | |||||||||||
cash-flows.row.capital-expenditure | 0 | -305.7 | -285.1 | -235.1 | |||||||||||
cash-flows.row.free-cash-flow | 0 | -219.9 | -156.6 | 438.2 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1518.8 | 1434.1 | 1994.3 | |||||||||||
income-statement-row.row.cost-of-revenue | 0 | 527.8 | 333.9 | 311.1 | |||||||||||
income-statement-row.row.gross-profit | 0 | 991 | 1100.2 | 1683.3 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | 0 | -43.9 | 25.7 | 19.8 | |||||||||||
income-statement-row.row.operating-expenses | 0 | 983.2 | 984.2 | 865.3 | |||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1511 | 1318.1 | 1176.3 | |||||||||||
income-statement-row.row.interest-income | 0 | 29.9 | 21 | 14.4 | |||||||||||
income-statement-row.row.interest-expense | 0 | 7.2 | 3.1 | 0.5 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 91.9 | 0 | -19.5 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | 0 | -43.9 | 25.7 | 19.8 | |||||||||||
income-statement-row.row.total-operating-expenses | 0 | 91.9 | 0 | -19.5 | |||||||||||
income-statement-row.row.interest-expense | 0 | 7.2 | 3.1 | 0.5 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 194.4 | 108.6 | 75.9 | |||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.operating-income | 0 | 7.8 | 147.5 | 822 | |||||||||||
income-statement-row.row.income-before-tax | 0 | 99.7 | 147.5 | 802.5 | |||||||||||
income-statement-row.row.income-tax-expense | 0 | 13.4 | 38.2 | 111 | |||||||||||
income-statement-row.row.net-income | 0 | 59 | 92.6 | 673.3 |
Vaak gestelde vragen
Wat is Double Medical Technology Inc. (002901.SZ) totale activa?
Double Medical Technology Inc. (002901.SZ) totale activa is 4639740860.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.667.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.040.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.042.
Wat is Double Medical Technology Inc. (002901.SZ) nettowinst (netto-inkomen)?
De nettowinst is 58972461.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 600196725.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 983165028.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.